6 results loaded, newest first. End of these results.
News 2026-10-16 08:33 UTC
EQS-News: Chainwire / Key word(s): Miscellaneous INmune Bio Inc. and Quantum Computing Inc. Partner to Apply Quantum Optimization and AI to Advance Alzheimer’s Drug Research and Explore New Applications for XPro 16.10.2026 / 10:30 CET/CEST The issuer is solely responsible for the content of this announcement. ═════════
News 2026-10-14 16:37 UTC
The companies will use Quantum Computing's Dirac-3S quantum optimization machine, artificial intelligence and data analytics to identify new applications for a drug.
News 2026-10-14 12:46 UTC
INmune Bio entered a collaboration with Quantum Computing to apply quantum computing, AI, and analytics to expand research on XPro1595. Work will use QCi’s Dirac-3S quantum optimization machine with clinical and public datasets to identify new indications and biomarkers. Partnership targets diseases with biology aligne
News 2026-10-14 12:45 UTC
The companies will apply quantum optimization and AI to advance Alzheimer’s drug research and explore new applications for XPro.
News 2026-10-14 12:36 UTC
Quantum Computing entered a collaboration with INmune Bio to apply quantum optimization, AI, and analytics to Alzheimer’s drug research. Work will use QCi’s Dirac-3S quantum optimization machine to identify new indications and biomarkers for INmune Bio’s XPro (XPro1595). Project will analyze INmune Bio clinical-trial d
News 2026-10-14 12:31 UTC
The companies will apply quantum optimization and AI to Alzheimer’s drug research and explore other applications for XPro.